ResearcherWan Fang HospitalNo recent work listed
Shyr-Yi Lin
Matched on OpenAlex author ID A5113568422.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 0, last author 1)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 4
2022: 1 paper · 2023: 1 paper
Papers 2
- Synergistic Combination of Irinotecan and Rapamycin Orally Delivered by Nanoemulsion for Enhancing Therapeutic Efficacy of Pancreatic Cancer. Co-author DOI 10.3390/pharmaceutics15020473↗
- Development of Irinotecan Liposome Armed with Dual-Target Anti-Epidermal Growth Factor Receptor and Anti-Fibroblast Activation Protein-Specific Antibody for Pa… Last author DOI 10.3390/pharmaceutics14061202↗
Closest collaborators
The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Yu-Hsuan Liu · 1 shared paper, 2023
- Hong-Liang Lin · 1 shared paper, 2023
- Chien-Ming Hsieh · 1 shared paper, 2023
- Hung-Jun Lin · 1 shared paper, 2022
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.